Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Development of new HLA-B*3505 genotyping method using Invader assay.
Culturally sensitive integration of supportive and cognitive behavioral therapy in the treatment of a bicultural dysthymic patient.
Hyperbaric oxygen therapy for a neurologically devastated child: whose decision is it?
Physician counseling, informed consent and parental decision making for infants with hypoplastic left-heart syndrome.
Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials.
Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials. Clin Cancer Res. 2016 Feb 01; 22(3):527-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions
Humans
Maximum Tolerated Dose
Research Design
authors with profiles
Mark Ratain